期刊文献+

东北某三甲医院2019年病原菌检测及耐药性分析 被引量:2

Analysis of pathogenic bacteria and their drug resistance in a 3A grade hospital in Northeast China in 2019
下载PDF
导出
摘要 目的:了解黑龙江省七台河市人民医院临床分离病原菌的分布情况及对抗菌药物的耐药性。方法:收集2019年1月1日-12月31日七台河市人民医院临床分离菌株,用自动化仪器法进行药敏试验,依据CLSI 2019版判读药敏结果,并采用WHONET 5.6软件进行数据分析。结果:2019年共收集临床分离菌3013株,其中革兰阳性菌632株(占21.0%),革兰阴性菌2381株(占79.0%);肺炎克雷伯菌、大肠埃希菌和金黄色葡萄球菌占检出病原菌的前3位;耐甲氧西林金黄色葡萄球菌(MRSA)占检出金黄色葡萄球菌的26.1%(59/226株),耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)占检出凝固酶阴性葡萄球菌的63.9%(115/180株)。肠球菌对利奈唑胺和替考拉宁均表现为敏感。大肠埃希菌、克雷伯菌属和奇异变形杆菌中超广谱β-内酰胺酶的检出率分别为47.0%(209株)、15.3%(130株)、13.3%(8株)。肠杆菌科细菌对碳青霉烯类抗生素的耐药率较低,耐碳青霉烯类肠杆菌(CRE)的检出率为2.7%(44/1636株)。非发酵革兰阴性杆菌中,铜绿假单胞菌对亚胺培南和美罗培南的耐药率分别为23.4%(55/235株)和20.9%(49/235株),相比之下鲍曼不动杆菌对上述两种碳青霉烯类抗生素的耐药率较高,分别为68.7%(145/211株)和67.3%(142/211株)。结论:2019年我院MRSA检出率较低。发现1例屎肠球菌对万古霉素耐药。除万古霉素、利奈唑胺、替考拉宁对多种细菌敏感外,MRSA和MRCNS对利福平、肺炎链球菌对青霉素和左氧氟沙星,铜绿假单胞菌对哌拉西林/他唑巴坦、头孢他啶和阿米卡星的敏感率较高。 Objective:To investigate the distribution of pathogenic bacteria clinically isolated in Qitaihe People's Hospital in 2019 and their resistance to antibiotics.Methods:The clinically isolated strains were collected during Jan.1st-Dec.31st,2019,and drug sensitive test was performed with automated system.The results were analyzed with WHONET 5.6 software according to the 2019 breakpoints of Clinical and Laboratory Standards Institute.Results:A total of 3013 strains of pathogenic bacteria were isolated,of which 632(21.0%)were Gram-positive strains and 2381(79.0%)were Gram-negative strains.Klebsiella pneumonia,Escherichia coli,Staphylococcus aureus were the most common pathogens.About 26.1%(59/226 strains)of Staphylococsus aureus isolates and 63.9%(115/180 strains)of coagulase negative Staphylococcus(CNS)isolates were resistant to methicillin.No Enterococcus species were found resistant to linezolid or teicoplanin.The detection rate of extended spectrumβlactamases(ESBLs)was 47.0%(209 strains)in Escherichia coli,15.3%(130 strains)in Klebsiella sp.and 13.3%(8 strains)in Proteus mirabilis strains.Enterobacteriaceae strains showed a low resistance to carbapenem antibiotics,and the detection rate of carbapenemresistant Enterobacter sp.(CRE)was 2.7%(44/1636 strains).About 23.4%(55/235 strains)and 20.9%(49/235 strains)of Pseudomonas aeruginosa isolates were resistant to imipenem and meropenem.By contrast,the resistance rate of Acinetobacter baumannii to imipenem and meropenem was 68.7%(145/211 strains)and 67.3%(142/211 strains),respectively.Conclusions:The isolated rate of methicillin-resistant Staphylococcus aureus(MRSA)is lower in 2019 in authors’hospital.One strain of vancomycin-resistant enterococcus faecium is found.Vancomycin,linezolid and teicoplanin are still sensentive antibiotics for several kinds of bacteria.The sensitive rates of MRSA and methicillinresistant CNS(MRCNS)to rifampicin,Streptococcus pneumoniae to penicillin and levofloxacin,and Pseudomonas aeruginosa to piperacillin/tazobactam,ceftazidine and amikacin were highter.
作者 那春鑫 姜凤艳 刘国峰 孙颖骞 Na Chunxin;Jiang Fengyan;Liu Guofeng;Sun Yingqian(Qitaihe People's Hospital,Qitaihe,Heilongjiang 154600,China)
出处 《感染.炎症.修复》 2020年第4期215-219,共5页 Infection Inflammation Repair
关键词 细菌耐药 抗菌药物 药敏试验 Bacterial resistance Antimicrobial agent Drug susceptibility test
  • 相关文献

参考文献8

二级参考文献72

  • 1余素明,廖云星,李乔俊,司予倩,孙婧,吴明,石凤丽.儿科院内感染分析及对策[J].感染.炎症.修复,2005,6(2):93-95. 被引量:4
  • 2季淑娟,顾怡明,谭文涛,王丹丹,冯羡菊,周志慧,俞云松,陈亚岗,李兰娟.中国部分地区大肠埃希菌和肺炎克雷伯菌超广谱β内酰胺酶基因型研究[J].中华检验医学杂志,2004,27(9):590-593. 被引量:172
  • 3刘杨,吴菊芳,萧正伦,盛瑞媛,吕晓菊,陈燕,张婴元.1031例患者应用去甲万古霉素不良反应观察[J].中华内科杂志,2004,43(11):815-819. 被引量:46
  • 4朱德妹,张婴元,汪复,郭燕,蒋晓飞,倪语星,孙景勇,应春妹,汪雅萍,王传清,王爱敏,蒋燕群,汤瑾,张泓,李万华,沈燕雅,金文敏,周庭银,陈险峰,张蓓,黄卫春,杨海慧,卫颖珏,汤荣,丁星,吴丽桂,武楠,汪瑞忠,房华,吕新华,朱爱英.2009年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):403-413. 被引量:37
  • 5Martone WJ, Gaynes RP, Horan TC, et al. National Nosocomial Infections Surveillance (NNIS) semiannual report, May 1995: A report from the National Nosocomial Infections Surveillance (NNIS) System[J]. Am J Infect Control, 1995,23(6) : 377 385.
  • 6Parker CM, Kuasoglannis J, Muscedere J, et al. Ventilator-associ ated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes[J]. J Crit Care,2008,23(1) :18 -26.
  • 7E1 Solh AA, Alhajhusain A. Update on the treatment of Pseudo- monas aeruginosa pneumonia[J]. J Antimicrob Chemother, 2009, 64(2) : 229-238.
  • 8Kirschke DL, Jones TF, Craig AS, et al. Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufac- turing defect in bronchoscopes[J]. N Engl J Med,2003,348(3): 214-220.
  • 9Zavascki AP,Cruz RP,Goldani LZ. Risk factora for imipenem-re- sistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients [J]. J Hosp Infect, 2005,59(2) :96-101.
  • 10Kiratisin P, Chongthaleong A, Tan TY, et al. Comparative in vitro activity of carbapenems against major Gram negative pathogens: results of Asia-Pacific surveillance from the COMPACT Ⅱ study [J]. Int J Antimicrob Agents,2012,39(4) :311-316.

共引文献172

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部